Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bertics

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Journal of Steroid Biochemistry|April 1, 1986
The kinetic mechanism of the anterior pituitary progesterone 5 alpha-reductaseJ S Campbell, P J Bertics, H J Karavolas
Journal of Cellular Physiology. Supplement|January 1, 1987
Regulatory features of the epidermal growth factor receptorG N Gill, J B Santon, P J Bertics
Molecular and Cellular Endocrinology|June 1, 1987
Epidermal growth factor and its receptorG N Gill, P J Bertics, J B Santon
The Journal of Biological Chemistry|May 31, 1996
Calmodulin N-methyltransferase. Kinetics, mechanism, and inhibitorsL S Wright, P J Bertics, F L Siegel
Endocrinology|January 1, 1984
A high affinity inhibitor of pituitary progesterone 5 alpha-reductaseP J Bertics, C F Edman, H J Karavolas
The Journal of Biological Chemistry|February 7, 2001
ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesisM E Bates, V L Green, P J Bertics
Oncogene|November 17, 2009
Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domainB H Ozer, G J Wiepz, P J Bertics
Endocrinology|January 1, 1981
Ovarian regulation of hypothalamic and pituitary progestin-metabolizing enzyme activitiesJ E Krause, P J Bertics, H J Karavolas
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophilsM E Bates, P J Bertics, W W Busse
Journal of Cellular Biochemistry|January 1, 1985
Regulation of the epidermal growth factor receptor by phosphorylationP J Bertics, W Weber, C Cochet, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Steroid Biochemistry|April 1, 1986
The kinetic mechanism of the anterior pituitary progesterone 5 alpha-reductaseJ S Campbell, P J Bertics, H J Karavolas
Journal of Cellular Physiology. Supplement|January 1, 1987
Regulatory features of the epidermal growth factor receptorG N Gill, J B Santon, P J Bertics
Molecular and Cellular Endocrinology|June 1, 1987
Epidermal growth factor and its receptorG N Gill, P J Bertics, J B Santon
The Journal of Biological Chemistry|May 31, 1996
Calmodulin N-methyltransferase. Kinetics, mechanism, and inhibitorsL S Wright, P J Bertics, F L Siegel
Endocrinology|January 1, 1984
A high affinity inhibitor of pituitary progesterone 5 alpha-reductaseP J Bertics, C F Edman, H J Karavolas
The Journal of Biological Chemistry|February 7, 2001
ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesisM E Bates, V L Green, P J Bertics
Oncogene|November 17, 2009
Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domainB H Ozer, G J Wiepz, P J Bertics
Endocrinology|January 1, 1981
Ovarian regulation of hypothalamic and pituitary progestin-metabolizing enzyme activitiesJ E Krause, P J Bertics, H J Karavolas
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophilsM E Bates, P J Bertics, W W Busse
Journal of Cellular Biochemistry|January 1, 1985
Regulation of the epidermal growth factor receptor by phosphorylationP J Bertics, W Weber, C Cochet, et al.
Pageof 7